GSK3B and chronic obstructive pulmonary disease: We demonstrate that levels of inactive GSK3β are enhanced in monocytes, macrophages, and bronchial epithelial cells from COPD patients compared with smokers and nonsmokers and that oxidative stress-induced GSK3β inhibition regulates glucocorticoid responsiveness in both monocytes/macrophages and bronchial epithelial cells.